1. Mitochondria-targeted antioxidant SkQR1 selectively protects MDR (Pgp 170)-negative cells against oxidative stress.
- Author
-
Fetisova EK, Avetisyan AV, Izyumov DS, Korotetskaya MV, Chernyak BV, and Skulachev VP
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics, Cell Line, Cell Line, Tumor, Cell Survival drug effects, Humans, Mitochondria drug effects, Plastoquinone metabolism, Plastoquinone pharmacology, ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, Antioxidants metabolism, Antioxidants pharmacology, Mitochondria metabolism, Oxidative Stress drug effects, Plastoquinone analogs & derivatives, Rhodamines metabolism, Rhodamines pharmacology
- Abstract
A conjugate of plastoquinone with decylrhodamine 19 (SkQR1) selectively accumulates in mitochondria of normal and tumor cells. SkQR1 protected the cellular pool of reduced glutathione under oxidative stress. Overexpression of P-glycoprotein (Pgp 170) multidrug resistance pump strongly suppresses accumulation of SkQR1. The inhibitors of Pgp 170 stimulate accumulation of SkQR1 in various cell lines indicating that SkQR1 is a substrate of Pgp 170. The protective effect of SkQR1 against oxidative stress is diminished in the cells overexpressing Pgp 170. It is suggested that mitochondria-targeted antioxidants could selectively protect normal (Pgp 170-negative) cells against the toxic effect of anti-cancer treatments related to oxidative stress., (2009. Published by Elsevier B.V.)
- Published
- 2010
- Full Text
- View/download PDF